1. Home
  2. MDGL vs HII Comparison

MDGL vs HII Comparison

Compare MDGL & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$551.35

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

HOLD

Current Price

$285.80

Market Cap

11.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
HII
Founded
2011
1886
Country
United States
United States
Employees
N/A
44000
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
11.5B
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
MDGL
HII
Price
$551.35
$285.80
Analyst Decision
Strong Buy
Buy
Analyst Count
12
6
Target Price
$674.45
$411.33
AVG Volume (30 Days)
306.0K
456.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
1.52%
EPS Growth
41.32
10.24
EPS
N/A
3.79
Revenue
$180,133,000.00
$12,484,000,000.00
Revenue This Year
$58.39
$4.82
Revenue Next Year
$48.55
$6.28
P/E Ratio
N/A
$76.24
Revenue Growth
N/A
8.23
52 Week Low
$286.75
$250.91
52 Week High
$615.00
$460.00

Technical Indicators

Market Signals
Indicator
MDGL
HII
Relative Strength Index (RSI) 61.89 42.58
Support Level $498.59 $276.16
Resistance Level $572.20 $293.78
Average True Range (ATR) 21.95 8.05
MACD 5.25 2.52
Stochastic Oscillator 77.24 45.38

Price Performance

Historical Comparison
MDGL
HII

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: